Surrozen (SRZN) Operating Leases (2020 - 2026)
Surrozen (SRZN) recorded quarterly Operating Leases of $4.9 million in Q1 2026, down 9.31% quarter-over-quarter from $5.3 million in Q4 2025, and down 28.43% on a YoY basis from $6.8 million in Q1 2025.
Surrozen (SRZN) Operating Leases (2020 - 2026) Analysis & Trends
Surrozen's Operating Leases history runs 7 years deep, the most recent figure standing at $4.9 million for Q1 2026.
- In Q1 2026, Operating Leases fell 28.43% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (down 28.43% YoY), while the FY2025 annual figure was $5.3 million, down 19.44% from the prior year.
- Operating Leases was $4.9 million for Q1 2026 at Surrozen, down from $5.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $6.8 million in Q1 2025 to a low of $223000.0 in Q1 2024.
- Historically, Operating Leases has averaged $4.0 million across 5 years, with a median of $4.5 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Operating Leases tumbled 91.99% in 2024, then soared 2939.46% in 2025.
- A 5-year view of Operating Leases shows it stood at $3.4 million in 2022, then sank by 73.87% to $882000.0 in 2023, then surged by 652.83% to $6.6 million in 2024, then slipped by 19.44% to $5.3 million in 2025, then decreased by 9.31% to $4.9 million in 2026.
- The last three Operating Leases figures came in at $4.9 million (Q1 2026), $5.3 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Surrozen | 225,877.86 | -106.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.85 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.78 Mn |
| Dec 31, 2024 | 6.64 Mn |
| Mar 31, 2024 | 223,000.00 |
| Dec 31, 2023 | 882,000.00 |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 3.38 Mn |
| Sep 30, 2022 | 3.96 Mn |
| Jun 30, 2022 | 4.53 Mn |
| Mar 31, 2022 | 5.07 Mn |
| Dec 31, 2021 | 5.60 Mn |
| Sep 30, 2021 | 6.06 Mn |
| Dec 31, 2020 | 7.49 Mn |